Information Provided By:
Fly News Breaks for November 1, 2019
DBD
Nov 1, 2019 | 04:52 EDT
JPMorgan analyst Paul Coster upgraded Diebold Nixdorf to Neutral from Underweight with a $7 price target. The analyst views the stock's risk/reward as balanced at current levels.
News For DBD From the Last 2 Days
There are no results for your query DBD